Last 33.20 INR
Change Today +0.80 / 2.47%
Volume 14.7K
ISL On Other Exchanges
Natl India
As of 12:17 AM 10/20/14 All times are local (Market data is delayed by at least 15 minutes).

ind-swift laboratories ltd (ISL) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/3/14 - 57.60
52 Week Low
10/31/13 - 24.60
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

ind-swift laboratories ltd (ISL) Related Businessweek News

No Related Businessweek News Found

ind-swift laboratories ltd (ISL) Details

Ind-Swift Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India and internationally. The company operates through Bulk Drugs & Pharmaceuticals segment. It primarily offers APIs in various therapeutic areas, including macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsychotic, bone resorption inhibitor, antimigraine, Parkinson disease, hyperparathyroidism, analgesic, aromatase inhibitor, nootropic, antihypertensive, antibacterial Quinolone, antidiarrhoeal, alcohol abstinence, antineoplastic, prostatic hyperplasia, and treatment of premature ejaculation; and others in glucocorticoids therapeutic area. The company also provides various products that are under development stage in prostatic hypertrophy, overactive bladder syndrome, and osteoporosis therapeutic areas. In addition, it offers menthol and mint derivatives under the Ind COOL brand. Further, the company provides contract research and manufacturing services, including early phase drug development, process research and development, custom chemical synthesis, contract and API manufacturing, and FTE, as well as analytical and regulatory submission support services. Ind-Swift Laboratories Limited was founded in 1995 and is based in Manimajra, India.

Founded in 1995

ind-swift laboratories ltd (ISL) Top Compensated Officers

Vice Chairman, Managing Director, Chief Execu...
Total Annual Compensation: 18.0M
Joint Managing Director, Whole Time Director ...
Total Annual Compensation: 18.0M
Executive Director
Total Annual Compensation: 4.8M
Compensation as of Fiscal Year 2014.

ind-swift laboratories ltd (ISL) Key Developments

Ind-Swift Laboratories Ltd. Approves Adoption of New Articles of the Company

Ind-Swift Laboratories Ltd. announced that at the annual general meeting held on September 30, 2014, shareholders of the company approved the adoption of new articles of the company.

Ind-Swift Laboratories Ltd., Annual General Meeting, Sep 30, 2014

Ind-Swift Laboratories Ltd., Annual General Meeting, Sep 30, 2014.

Ind-Swift Laboratories Ltd. Announces Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2014

Ind-Swift Laboratories Ltd. announced unaudited standalone earnings results for the first quarter ended June 30, 2014. For the quarter, the company reported total net sales of INR 1,886.128 million compared to INR 2,531.943 million a year ago. Profit from operations before other income, interest and exceptional items was INR 110.569 million compared to INR 193.208 million a year ago. Loss from ordinary activities before tax was INR 171.133 million compared to INR 78.989 million a year ago. Loss from ordinary activities after tax was INR 171.151 million or INR 4.18 per basic and diluted share compared to INR 78.989 million or INR 2.01 per basic and diluted share a year ago.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ISL:IN 33.20 INR +0.80

ISL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ISL.
View Industry Companies

Industry Analysis


Industry Average

Valuation ISL Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IND-SWIFT LABORATORIES LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at